#liver cancer

NIH Scientists Develop Blood Test to Help Improve Liver Cancer Screening

New insights into why men fail to mount as powerful an immune response to many cancers as women do.

Universal HCV testing led to an increase in the number of pregnant women and infants diagnosed in a timely manner.

Only 30% of U.S. adults have been vaccinated against the liver disease. Here’s how the Hepatitis B Foundation aims to change that.

Screening for hepatitis B virus and liver cancer prevention were promoted through the KakaoTalk app.

Cases of the most common type of liver cancer, hepatocellular carcinoma, are on the rise.

Noninvasive imaging may be the best way to screen for NAFLD in this population.

Three checkpoint inhibitors reduce the risk of death for patients with hard-to-treat liver and biliary tract cancers.

A majority of people with alcohol-related liver cirrhosis may have normal ALT levels.

Abdominal obesity worsened the impact of air pollution on MAFLD development.

The PreHevbrio vaccine produces higher antibody levels and offers faster protection.

The drug, which blocks entry of HBV into liver cells, also prevents HDV replication.

Among babies with Beckwith-Wiedemann Syndrome, scientist are identifying which genetic changes are more likely to cause cancers.

Hepatocellular carcinoma can still occur after hepatitis C is cured, and risk factors differ for people with and without cirrhosis.

Over the next two decades, obesity-linked NASH will lead to more deaths and high cost in the United States.

Research has shown that elevated levels of iron in the blood from hereditary hemochromatosis can raise the risk of HCC.

From 1995 to 2016, hepatocellular carcinoma incidence in rural populations climbed by 218%.